SEC Tracker
Get the app

ProMIS Neurosciences PMN

Neil Cashman (Chief Scientific Officer) bought 10,000 PMN at $3.86, worth $39K

Form
4
Filed
Importance
Notable
  1. Neil Cashman acquired 10,000 common shares at $3.86
  2. Cashman owns 14,532 direct shares
  3. 4,122 shares held indirectly through Research Capital Corporation
  4. 664 shares held indirectly by his spouse

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when ProMIS Neurosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  2. Tempest Therapeutics TPST public float $30M, Jun 30, 2025
  3. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  4. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  5. Champions Oncology CSBR public float $29M, Oct 31, 2025